Clinical trial reports

  • Which Sites Are Most Active in European Lymphoma Phase II and III Trials?
  • Which sites are most active in European Phase II–III colorectal cancer trials?
  • Which sites anchor Phase II–III liver cancer trial activity in Europe?
  • Which European Sites Are Most Active in Phase II–III Kidney Cancer Trials?
  • Which EU sites are most active in diabetes Phase II–III trials?
  • Which Sites Are Most Active in European Cardiology Phase II–III Trials?
  • When Do Phase III Oncology–Haematology Trials Use PFS-Family Primary Endpoints?
  • Oncology Phase III Endpoint Architecture, 2024–2026
  • Does PFS Displace OS as the Primary Endpoint in Phase III Lymphoma Trials?
  • OS vs PFS as Primary Endpoints in Phase III Colorectal Cancer Trials
  • When Do Kidney Cancer Phase III Trials Use OS Instead of PFS?
  • Where Do OS and PFS Sit in Phase III Pancreatic Cancer Trials?